The Leukemia & Lymphoma Society (LLS) is a 501(c)(3) charitable organization founded in 1949 and headquartered in Rye Brook, New York, dedicated to curing blood cancers and improving patient quality of life through research funding, advocacy, and support services.
Meaning and Symbolism
- The bold red (#cc0000) represents blood, hope, and the urgent fight against leukemia, lymphoma, Hodgkin’s disease, and myeloma
- Red conveys both the medical nature of the mission (blood disorders) and the passionate commitment to finding cures and supporting patients
- Gray (#5e5f61) provides professional grounding and stability, balancing emotional urgency with organizational credibility
- The abstract mark suggests interconnected elements, representing the comprehensive approach of research, patient services, and advocacy
- The combination of vibrant red and neutral gray creates visual impact while maintaining the dignity and seriousness appropriate for health nonprofits
History and Evolution
The Leukemia & Lymphoma Society was founded in 1949 by Rudolph and Antoinette de Villiers following the death of their 16-year-old son Robert from leukemia. At the time, childhood leukemia was virtually untreatable with survival rates near zero. The grieving parents channeled their loss into action, creating an organization dedicated to funding research and finding cures. Originally called the De Villiers Foundation, it later became the Leukemia Society and eventually expanded its mission to include all blood cancers, adopting the current name to reflect the broader scope.
LLS grew into the world’s largest voluntary health organization focused on blood cancers, establishing 56 chapters throughout the United States and five chapters in Canada. The organization pioneered models for nonprofit disease advocacy, including the Team in Training program launched in 1988, which combines athletic endurance events with fundraising. This innovative approach has trained over 650,000 participants for marathons, triathlons, and cycling events while raising over $1.7 billion for blood cancer research and services.
LLS has invested over $1.5 billion in cancer research since inception, funding many breakthrough therapies that transformed blood cancer from a death sentence to a manageable or curable condition. Childhood leukemia survival rates have increased from near zero in 1949 to over 90% today, a testament to the impact of sustained research investment. Beyond research, LLS provides patient services including financial assistance, education programs, support groups, and advocacy for policies ensuring access to care. The organization operates from headquarters in Rye Brook, New York, coordinating research priorities, patient services, and fundraising efforts nationally.
Typography and Design
The Leukemia & Lymphoma Society wordmark employs professional, accessible typography that balances medical authority with approachability. The letterforms convey trustworthiness and stability, essential qualities for an organization stewarding millions in donations and serving vulnerable patient populations. The design ensures readability across diverse contexts from medical conferences to community fundraising events, maintaining dignity while remaining welcoming to patients, families, and supporters at all levels.
The signature red (#cc0000) creates immediate emotional resonance, evoking both the blood disorders at the heart of LLS’s mission and the urgent hope for cures. This bold red appears consistently across materials, creating strong brand recognition at races, galas, and awareness campaigns. The color choice distinguishes LLS from other health nonprofits while maintaining the seriousness appropriate for organizations addressing life-threatening diseases.
The neutral gray (#5e5f61) provides necessary balance, preventing the visual identity from becoming overwhelming while adding professional polish. This grounding color appears in supporting text, backgrounds, and secondary brand elements, ensuring materials remain readable and appropriate for clinical, corporate, and community settings. The abstract mark likely incorporates elements suggesting interconnectedness or cellular structures, visually representing LLS’s comprehensive approach spanning research laboratories to patient bedsides.
Frequently Asked Questions
When was the Leukemia & Lymphoma Society founded? LLS was founded in 1949 by Rudolph and Antoinette de Villiers after their 16-year-old son Robert died from leukemia, which was virtually untreatable at the time.
How much has LLS invested in cancer research? The Leukemia & Lymphoma Society has invested over $1.5 billion in blood cancer research since its founding, helping increase childhood leukemia survival rates from near zero to over 90% today.
Where is LLS headquartered? LLS is headquartered in Rye Brook, New York, and operates 56 chapters throughout the United States plus five chapters in Canada.
More logos with similar colors
